Hepatorenal polycystic diseases research hub

Efficacy and safety of Ursodeoxycholic Acid as a new therapy for the treatment of hepatorenal polycystic diseases, genetic study and determination of prognostic biomarkers.

This study is testing a medication called Ursodeoxycholic Acid for polycystic diseases affecting the liver and kidneys. Researchers want to see if it can shrink cysts and improve health. It's an early-stage study, focusing on safety and how well the treatment works in a small group of people.